verified SJR 0,903 · Q2 • database Scopus / SJR & Web of Science & Latindex indexed

Italy · Springer-Verlag Italia s.r.l...

workspace_premium Q2 — Medicine (miscellaneous) lock Subscription Unclaimed

Clinical and Translational Oncology

Clinical and Translational Oncology is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 65. It has a price of 3290 €. It has an SJR impact factor of 0,903 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,903.

Clinical and Translational Oncology focuses its scope in these topics and keywords: patients, cancer, melanoma, clinical, management, treatment, guideline, bevacizumab, nutritional, braf, ...

ISSN: 1699-048X

Editorial: Springer-Verlag Italia s.r.l.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedLatindex

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

0,903 Q2

H-index 65

Tasa de Aceptación pie_chart

30% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

3.290 € Subscription

Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science Latindex

SJR Impact

0,903

H-index

Docs (year)

483

Docs 3y

788

Total refs

22402

Cites 3y

2363

Citable 3y

771

Cites/Doc 2y

2.96

Ref/Doc

46.38

Immediate OA

3290 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Breast cancer: process of awareness

Whole brain irradiation and temozolomide based chemotherapy in melanoma brain metastases

Comparative analysis of loss of heterozygosity and expression profi le in normal tissue, DCIS and invasive breast cancer

Combined oral cyclophosphamide and bevacizumab in heavily pre-treated ovarian cancer

Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (CRPC): a post hoc analysis of two randomized clinical trials

CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo

Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients

Clinical guideline SEOM: cancer of unknown primary site

Clinical guide SEOM on venous thromboembolism in cancer patients

Classification of ovarian carcinomas based on pathology and molecular genetics

Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism

Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment

SHOW MORE ARTICLES

Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables

A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products

Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Bevacizumab for recurrent, persistent or advanced cervical cancer: reproducibility of GOG 240 study results in "real world" patients

Baseline 18F-Fluorocholine PET/CT and bone scan in the outcome prediction of patients treated with radium 223 dichloride

Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics

APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study

Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma

Adrenal metastasis of breast cancer with involvement of the inferior vena cava

Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer

Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)

Absorbed dose and transmission factor in blocked fields for radiotherapy treatments with 6 MV X-ray

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.